Joseph R. Martin - 14 Jun 2023 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reporting relationship: General Counsel
Issuer ticker: CLOV
Reported as of: 14 Jun 2023
Net transaction value: -$92,897
SEC form: 4
Accepted by SEC: 16 Jun 2023, 16:03:39 UTC
Prior SEC filing: 26 Apr 2023
Next SEC filing: 21 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Joseph R. Martin

Key filing fact

Joseph R. Martin filed Form 4 for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) on 16 Jun 2023.

Key facts

This page summarizes Joseph R. Martin's Form 4 filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jun 2023, 16:03.

Change

Previous filing in this sequence was filed on 26 Apr 2023.
Current net transaction value: -$92,897.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLOV transaction

Class A Common Stock

Tax liability

Transaction value: $92,897
Shares: -98,827
Change %: -3.5%
Price: $0.9400
Shares after: 2,718,857
Date: 14 Jun 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on June 16, 2023, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022, and timely reported on a Form 4 filed on March 15, 2022. The remaining RSUs will vest quarterly in equal installments of 6.25%, with the final vesting date occurring on March 17, 2026, subject to the continued service of the Reporting Person on each such vesting date.